Bliss GVS Pharma Ltd

BLISSGVS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,046 cr, stock is ranked 943
High RiskStock is 3.07x as volatile as Nifty
100.952.35 (+2.38%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,046 cr, stock is ranked 943
High RiskStock is 3.07x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
15.28
PB RatioPB Ratio
1.26
Dividend YieldDiv. Yield
0.49%
Sector PESector PE
38.07
Sector PBSector PB
5.10
Sector Div YldSctr Div Yld
0.67%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021841.18936.20728.50597.4358.78123.7397.2668.51
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Loss of Share Certificates 
Announced OnNov 25, 2021

Bliss GVS Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

Bliss GVS Pharma Limited has informed the Exchange about Loss of Share Certificates | Download

ESOP/ESOS/ESPS 
Announced OnNov 18, 2021

Bliss GVS Pharma Limited has informed the Exchange regarding Allotment of 169000 Shares. | Download

Bliss GVS Pharma Limited has informed the Exchange regarding Allotment of 169000 Shares. | Download

Cash Dividend 
Ex. DateSep 13, 2021

Final • Div/Share: ₹ 0.5

See all events